A detailed history of Sih Partners, Lllp transactions in Biogen Inc. stock. As of the latest transaction made, Sih Partners, Lllp holds 10,414 shares of BIIB stock, worth $1.41 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,414
Holding current value
$1.41 Million
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$133.43 - $153.27 $1.39 Million - $1.6 Million
10,414 New
10,414 $1.43 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $19.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Sih Partners, Lllp Portfolio

Follow Sih Partners, Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sih Partners, Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Sih Partners, Lllp with notifications on news.